- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£966GBP
- Report
- October 2024
- 210 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- June 2024
- 260 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- January 2025
- 250 Pages
Global
From €4550EUR$4,999USD£3,865GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €2538EUR$2,789USD£2,156GBP
- Report
- December 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- June 2024
- 200 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- June 2024
- 145 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- April 2025
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- March 2025
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2025
- 183 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- August 2024
- 18 Pages
Global
From €13648EUR$14,995USD£11,592GBP
- Report
- August 2024
- 121 Pages
Global
From €13648EUR$14,995USD£11,592GBP
- Report
- February 2025
- 60 Pages
Global
From €9097EUR$9,995USD£7,727GBP
- Report
- March 2024
- 150 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- August 2022
- 117 Pages
Global
From €4096EUR$4,500USD£3,479GBP

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics.
The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more